Clinical Trial

Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients

Name: Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients — clinical trial record (NCT07581145)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SEMAFOOT2

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The aim of this exploratory pilot study is to investigate the effect of semaglutide compared to placebo on healing of foot ulcers in type 2 diabetes patients. It is a randomized double blind, placebo controlled, clinical intervention study of 20 weeks intervention.

Trial Details

NCT Number	NCT07581145
Lead Sponsor	Ole Lander Svendsen
Conditions	Foot Ulcer Due to Type 2 Diabetes Mellitus
Enrollment	52 participants
Start Date	2026-04-24
Primary Completion	2028-12 (estimated)
Study Completion	2029-12 (estimated)
Updated on ClinicalTrials.gov	2026-05-12